Age-Related Macular Degeneration (AMD) Market Outlook to 2023 - Key players are F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals co.
The Prominent Market Research presents a comprehensive assessment of the PMR market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set
(EMAILWIRE.COM, August 16, 2018 ) Woodridge, USA August 2018 (News) - Age-Related Macular Degeneration (AMD) Market is a condition that affects the back of the eye called the macula. AMD is described as either dry or wet AMD.
Age-related macular degeneration causes progressive damage to the macula, resulting in gradual loss of central vision. There are two types of AMD, namely, dry (nonexudative or atrophic), and wet (neovascular or exudative). About 80 to 90% of the people with AMD have only the dry type. The market growth is mainly driven by the rising prevalence of AMD in the geriatric population and off-patent of blockbuster drugs.
Age-related macular degeneration is an ocular disease that involves the posterior aspect of the retina called the macula. The wet form of AMD is less frequent but is responsible for 90% of the acute blindness due to AMD.
Get Free Sample Report: https://www.prominentmarketresearch.com/sample-report/71441
Key Players:
• F. Hoffmann-La Roche AG,
• Regeneron Pharmaceutical Inc.,
• Novartis AG,
• Bayer AG,
• Santen Pharmaceuticals co.
Ask For Report Discount: https://www.prominentmarketresearch.com/discount-report/71441
Key Findings:
•The major market players in the global age-related macular degeneration market are F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals co, and others
•F. Hoffmann-La Roche AG accounted for more than 13.2% share of the global age-related macular degeneration market
•Based on type, the wet age-related macular degeneration segment commanded the largest market share in 2017 and was valued at USD 4,423.5 million in 2017
•Based on stages, the intermediate Age-Related Macular Degeneration (AMD) segment commanded the largest market share in 2017 and was valued at USD 3,224.6 million in 2017
•On the basis of region, the American region is projected to be the fastest growing region, at a CAGR of 7.86% during the forecast period.
Buy Report: https://www.prominentmarketresearch.com/checkout/71441
Target Audience:
• Pharmaceutical and Medical Device Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Manager
• Research Companies.
About Us:
Prominent market Research was established in 2018 with an energetic team of competent professional to take on the challenges of market analysis in the capacity of market insight needs. We deliver the benefits of this expertise to you through our market research insights and people to help you make better decisions and achieve better results.
Age-related macular degeneration causes progressive damage to the macula, resulting in gradual loss of central vision. There are two types of AMD, namely, dry (nonexudative or atrophic), and wet (neovascular or exudative). About 80 to 90% of the people with AMD have only the dry type. The market growth is mainly driven by the rising prevalence of AMD in the geriatric population and off-patent of blockbuster drugs.
Age-related macular degeneration is an ocular disease that involves the posterior aspect of the retina called the macula. The wet form of AMD is less frequent but is responsible for 90% of the acute blindness due to AMD.
Get Free Sample Report: https://www.prominentmarketresearch.com/sample-report/71441
Key Players:
• F. Hoffmann-La Roche AG,
• Regeneron Pharmaceutical Inc.,
• Novartis AG,
• Bayer AG,
• Santen Pharmaceuticals co.
Ask For Report Discount: https://www.prominentmarketresearch.com/discount-report/71441
Key Findings:
•The major market players in the global age-related macular degeneration market are F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals co, and others
•F. Hoffmann-La Roche AG accounted for more than 13.2% share of the global age-related macular degeneration market
•Based on type, the wet age-related macular degeneration segment commanded the largest market share in 2017 and was valued at USD 4,423.5 million in 2017
•Based on stages, the intermediate Age-Related Macular Degeneration (AMD) segment commanded the largest market share in 2017 and was valued at USD 3,224.6 million in 2017
•On the basis of region, the American region is projected to be the fastest growing region, at a CAGR of 7.86% during the forecast period.
Buy Report: https://www.prominentmarketresearch.com/checkout/71441
Target Audience:
• Pharmaceutical and Medical Device Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Manager
• Research Companies.
About Us:
Prominent market Research was established in 2018 with an energetic team of competent professional to take on the challenges of market analysis in the capacity of market insight needs. We deliver the benefits of this expertise to you through our market research insights and people to help you make better decisions and achieve better results.
Contact Information:
Prominent Market Research
Robin
Tel: +1-815-957-4373
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Prominent Market Research
Robin
Tel: +1-815-957-4373
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results